Press Release Apr 07 2026

About this update from Biocon Limited

Biocon Limited has informed the Exchange regarding a press release dated April 07, 2026, titled "Biocon Announces U.S. Commercial Launch of Bosaya and Aukelso , Denosumab Biosimilars". View Attachment

View stock analysis, news, and events for Biocon Limited